2.0672

3.40% -0.0728

Ensysce Biosciences Inc (ENSC)

Overview News Price History Financials Discussions Forecast Stock Split

Ensysce Biosciences Inc stock is traded at $2.0672, with a volume of 22,892. It is down -3.40% in the last 24 hours and down -0.14% over the past month. Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Previous Close:

$2.14

Open:

$2.06

24h Volume:

22,892

Relative Volume:

0.01

Market Cap:

$5.55M

Revenue:

Net Income/Loss:

$-11.28M

P/E Ratio:

-0.6868

EPS:

-3.01

Net Cash Flow:

$-9.78M

1W Performance:

-13.14%

1M Performance:

-0.14%

6M Performance:

-63.22%

1Y Performance:

-74.00%

1-Day Range:

$2.05

$2.14

1-Week Range:

$1.99

$2.4699

52-Week Range:

$1.62

$14.67

Ensysce Biosciences Inc Stock (ENSC) Company Profile

Name

Ensysce Biosciences Inc

Sector

Healthcare (1174)

Industry

Biotechnology (661)

Phone

(858) 263-4196

Address

7946 IVANHOE AVENUE, LA JOLLA

Employee

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

ENSC's Discussions on Twitter

Compare ENSC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ENSC Ensysce Biosciences Inc	2.0682	5.55M	0	-11.28M	-9.78M	-3.01
VRTX Vertex Pharmaceuticals Inc	459.11	113.97B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	524.51	52.15B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	306.74	40.16B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	581.84	35.45B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	271.65	27.80B	3.81B	-644.79M	-669.77M	-6.24

Ensysce Biosciences Inc Stock (ENSC) Latest News

Jun 11, 2025

Leading Pain Experts Reveal New Opioid Abuse Prevention Technology at World's Largest Pain Conference - Stock Titan

Jun 11, 2025

(ENSC) On The My Stocks Page - news.stocktradersdaily.com

Jun 11, 2025

Jun 07, 2025

Ensysce Biosciences (NASDAQ:ENSC) Trading 1.7% Higher – Here’s What Happened - Defense World

Jun 07, 2025

Jun 05, 2025

Ensysce Biosciences (ENSC) Secures $5.3M Grant to Advance Opioid Development | ENSC Stock News - GuruFocus

Jun 04, 2025

Ensysce Biosciences secures additional $5.3M NIDA grant By Investing.com - Investing.com India

Jun 04, 2025

Revolutionary Opioid With Built-in Overdose Protection Secures $5.3M NIH Grant After FDA Breakthrough Status - Stock Titan

Jun 04, 2025

Jun 01, 2025

Ensysce Biosciences (NASDAQ:ENSC) Raised to Hold at Wall Street Zen - Defense World

Jun 01, 2025

May 29, 2025

When (ENSC) Moves Investors should Listen - news.stocktradersdaily.com

May 29, 2025

May 19, 2025

Where are the Opportunities in (ENSC) - news.stocktradersdaily.com

May 19, 2025

May 17, 2025

Zacks Small Cap Analysts Boost Earnings Estimates for ENSC - Defense World

May 17, 2025

May 16, 2025

Ensysce Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 16, 2025

May 15, 2025

Ensysce Biosciences Advances in Pain Relief Innovation - TipRanks

May 15, 2025

May 13, 2025

Revolutionary Opioid Treatment Proves Overdose-Proof in Clinical Trials, Secures Key Patent - Stock Titan

May 13, 2025

May 12, 2025

Ensysce Biosciences Bolsters Management Team with Regulatory Expert - Stock Titan

May 12, 2025

May 11, 2025

Head-To-Head Contrast: CV Sciences (OTCMKTS:CVSI) and Ensysce Biosciences (NASDAQ:ENSC) - Defense World

May 11, 2025

May 08, 2025

(ENSC) Trading Signals - news.stocktradersdaily.com

May 08, 2025

May 02, 2025

Ensysce Biosciences (ENSC) to Release Earnings on Friday - Defense World

May 02, 2025

Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025

Apr 25, 2025

Ensysce Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference - ACCESS Newswire

Apr 25, 2025

Ensysce Biosciences, Inc. Announces Closing of $3.0 Million Registered Direct Offering Priced at-the-Market Under NASDAQ Rules - ACCESS Newswire

Apr 25, 2025